JAMES REITH: Open Payments
NPI 1215943758 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 33 payments from 7 companies in 2025. Trend: 2023 $227 · 2024 $95 · 2025 $736
Food & beverage: $668Education: $69
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $230 |
| UCB, Inc. | 4 | $138 |
| Janssen Biotech, Inc. | 3 | $106 |
| Arcutis Biotherapeutics, Inc. | 3 | $96 |
| Novartis Pharmaceuticals Corporation | 5 | $81 |
| Incyte Corporation | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: OTEZLA, Bimzelx, TREMFYA, Zoryve, COSENTYX, OPZELURA, Sotyktu, Rhapsido.
Industry payments across CA — which companies pay providers there.
